Diabetic ketoacidosis elicits systemic inflammation associated with cerebrovascular endothelial cell dysfunction

Microcirculation

Volumn 20, Issue 6, 2013, Pages 534-543

  Close, Taylor E ^a,b   Cepinskas, Gediminas ^b,c   Omatsu, Tatsushi ^c   Rose, Keeley L ^a,b   Summers, Kelly ^b   Patterson, Eric K ^c   Fraser, Douglas D ^a,b,c  

^a CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Centre for Critical Illness Research   (Canada)

Author keywords

Blood brain barrier; Cytokines; Edema; Endothelial cells; Inflammation

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; CELL ADHESION MOLECULE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CELL ACTIVATION; CEREBROVASCULAR ENDOTHELIAL CELL; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; ENDOTHELIUM CELL; HEAT TREATMENT; INFLAMMATION; LEUKOCYTE ADHERENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; BRAIN; CELL CULTURE; LEUKOCYTE; LEUKOCYTE ROLLING; METABOLISM; PATHOLOGY;

ANIMALS; BRAIN; CELL ADHESION MOLECULES; CELLS, CULTURED; CYTOKINES; DIABETIC KETOACIDOSIS; ENDOTHELIAL CELLS; INFLAMMATION; LEUKOCYTE ROLLING; LEUKOCYTES; MALE; MICE;

EID: 84881499328     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/micc.12053     Document Type: Article

References (47)

1. Birukov KG. Regulation of vascular endothelial cell signal transduction and phenotype by mechanical factors. In: Microvascular Research: Biology and Pathology, edited by Shepro D. Burlington, Mass: Elsevier Academic Press, 2005.
2. Brasier AR. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86: 211-218, 2010.
3. Chiasson JL, Aris-Jilwan N, Belanger R, Bertrand S, Beauregard H, Ekoe JM, Fournier H, Havrankova J. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ 168: 859-866, 2003.
4. Dalton RR, Hoffman WH, Passmore GG, Martin SL. Plasma C-reactive protein levels in severe diabetic ketoacidosis. Ann Clin Lab Sci 33: 435-442, 2003.
5. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29: 313-326, 2009.
6. Figueroa RE, Hoffman WH, Momin Z, Pancholy A, Passmore GG, Allison J. Study of subclinical cerebral edema in diabetic ketoacidosis by magnetic resonance imaging T2 relaxometry and apparent diffusion coefficient maps. Endocr Res 31: 345-355, 2005.
7. Foster JR, Morrison G, Fraser DD. Diabetic ketoacidosis-associated stroke in children and youth. Stroke Res Treat 2011: 219706, 2011.
8. Frijns CJ, Kappelle LJ. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33: 2115-2122, 2002.
9. Girard N, Maingonnat C, Bertrand P, Vasse M, Delpech B. Hyaluronectin secretion by monocytes: downregulation by IL-4 and IL-13, upregulation by IL-10. Cytokine 11: 579-584, 1999.
10. Glaser NS, Wootton-Gorges SL, Marcin JP, Buonocore MH, Dicarlo J, Neely EK, Barnes P, Bottomly J, Kuppermann N. Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediatr 145: 164-171, 2004.
11. Gordin D, Forsblom C, Ronnback M, Parkkonen M, Waden J, Hietala K, Groop PH. Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes. Ann Med 40: 627-633, 2008.
12. Handa O, Stephen J, Cepinskas G. Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis. Am J Physiol Heart Circ Physiol 295: H1712-1719, 2008.
13. Hoffman WH, Casanova MF, Cudrici CD, Zakranskaia E, Venugopalan R, Nag S, Oglesbee MJ, Rus H. Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosis. Exp Mol Pathol 83: 65-72, 2007.
14. Hoffman WH, Cudrici CD, Zafranskaia E, Rus H. Complement activation in diabetic ketoacidosis brains. Exp Mol Pathol 80: 283-288, 2006.
15. Hoffman WH, Helman SW, Passmore G. Acute activation of peripheral lymphocytes during treatment of diabetic ketoacidosis. J Diabetes Complications 15: 144-149, 2001.
16. Hoffman WH, Siedlak SL, Wang Y, Castellani RJ, Smith MA. Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res 1369: 194-202, 2011.
17. Hoffman WH, Stamatovic SM, Andjelkovic AV. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res 1254: 138-148, 2009.
18. Hoffman WH, Steinhart CM, el Gammal T, Steele S, Cuadrado AR, Morse PK. Cranial CT in children and adolescents with diabetic ketoacidosis. AJNR Am J Neuroradiol 9: 733-739, 1988.
19. Ikeda T, Sato K, Kuwada N, Matsumura T, Yamashita T, Kimura F, Hatake K, Ikeda K, Motoyoshi K. Interleukin-10 differently regulates monocyte chemoattractant protein-1 gene expression depending on the environment in a human monoblastic cell line, UG3. J Leukoc Biol 72: 1198-1205, 2002.
20. Isales CM, Min L, Hoffman WH. Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J Diabetes Complications 13: 91-97, 1999.
21. Jain SK, Kannan K, Lim G. Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic Biol Med 25: 1083-1088, 1998.
22. Jain SK, Kannan K, Lim G, Matthews-Greer J, McVie R, Bocchini JA Jr. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 26: 2139-2143, 2003.
23. Jain SK, Rains JL, Croad JL. High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes. Antioxid Redox Signal 9: 1581-1590, 2007.
24. Jerath RS, Burek CL, Hoffman WH, Passmore GG. Complement activation in diabetic ketoacidosis and its treatment. Clin Immunol 116: 11-17, 2005.
25. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15: 412-426, 1999.
26. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678-689, 2007.
27. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734, 2002.
28. Lin JJ, Lin KL, Wang HS, Wong AM, Hsia SH. Occult infarct with acute hemorrhagic stroke in juvenile diabetic ketoacidosis. Brain Dev 30: 91-93, 2008.
29. Liu WY, Wang ZB, Zhang LC, Wei X, Li L. Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci Ther 18: 609-615, 2012.
30. Mahmud FH, Ramsay DA, Levin SD, Singh RN, Kotylak T, Fraser DD. Coma with diffuse white matter hemorrhages in juvenile diabetic ketoacidosis. Pediatrics 120: e1540-1546, 2007.
31. Markovic N, McCaig LA, Stephen J, Mizuguchi S, Veldhuizen RA, Lewis JF, Cepinskas G. Mediators released from LPS-challenged lungs induce inflammatory responses in liver vascular endothelial cells and neutrophilic leukocytes. Am J Physiol Gastrointest Liver Physiol 297: G1066-1076, 2009.
32. Miltenyi M, Tulassay T, Szabo A, Korner A, Seyberth HW. Urinary prostaglandins in hyperglycaemic ketoacidosis of type I diabetes mellitus. Pediatr Nephrol 4: 44-47, 1990.
33. Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T. Modulation of immune response by head injury. Injury 38: 1392-1400, 2007.
34. Oglesbee MJ, Herdman AV, Passmore GG, Hoffman WH. Diabetic ketoacidosis increases extracellular levels of the major inducible 70-kDa heat shock protein. Clin Biochem 38: 900-904, 2005.
35. Pachter JS, de Vries HE, Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 62: 593-604, 2003.
36. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1: 223-236, 2006.
37. Pettersson US, Christoffersson G, Massena S, Ahl D, Jansson L, Henriksnas J, Phillipson M. Increased recruitment but impaired function of leukocytes during inflammation in mouse models of type 1 and type 2 diabetes. PLoS ONE 6: e22480, 2011.
38. Rasband, W.S ., ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/, 1997-2005.
39. Roe TF, Crawford TO, Huff KR, Costin G, Kaufman FR, Nelson MD Jr. Brain infarction in children with diabetic ketoacidosis. J Diabetes Complications 10: 100-108, 1996.
40. Rose KL, Pin CL, Wang R, Fraser DD. Combined insulin and bicarbonate therapy elicits cerebral edema in a juvenile mouse model of diabetic ketoacidosis. Pediatr Res 61: 301-306, 2007.
41. Rosenbloom AL, Schatz DA, Krischer JP, Skyler JS, Becker DJ, Laporte RE, Libman I, Pietropaolo M, Dosch HM, Finberg L, Muir A, Tamborlane WV, Grey M, Silverstein JH, Malone JI. Therapeutic controversy: prevention and treatment of diabetes in children. J Clin Endocrinol Metab 85: 494-522, 2000.
42. Schroeter M, Jander S. T-cell cytokines in injury-induced neural damage and repair. NeuroMol Med 7: 183-195, 2005.
43. Silwedel C, Forster C. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli. J Neuroimmunol 179: 37-45, 2006.
44. Sredni-Kenigsbuch D. TH1/TH2 cytokines in the central nervous system. Int J Neurosci 112: 665-703, 2002.
45. Stanimirovic D, Satoh K. Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. Brain Pathol 10: 113-126, 2000.
46. Szelenyi J. Cytokines and the central nervous system. Brain Res Bull 54: 329-338, 2001.
47. Xiang M, Fan J, Fan J. Association of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury. Mediators Inflamm Article ID 916425, doi:10.1155/2010/916425, 2010.